Bioline Rx Ltd ADR (BLRX)

概要ニュース株価時系列オプションチェーンなぜBLRXが下落しているのか？ディスカッション予測株式分割

なぜBioline Rx Ltd ADR（BLRX）の株価が下がっていますか？

2024-05-15 の取引セッション中に、Bioline Rx Ltd ADR (BLRX) 株の 5.26% 下落を確認しました。これは通常のボラティリティやさまざまな内部および外部要因に起因する可能性がありますが、当社では状況を積極的に監視しており、できるだけ早くタイムリーな最新情報を提供することに注意してください。

2023-11-20:

Shares of BioLineRx (BLRX) dropped by 10.59% from $1.700 to $1.520 in the trading on Monday, November 20, 2023. The reason why BLRX is down today is due to the company's disappointing Q3 financial results.

Research and development expenses decreased by 37.6%, mainly due to reduced costs associated with NDA supporting activities and the completed AGI-134 clinical trial.
Sales and marketing expenses saw a significant 517.4% increase, driven by heightened pre-commercialization activities.
General and administrative expenses rose by 7.7% due to minor increases in various G&A expenses.
Non-operating expenses surged, primarily due to the revaluation of outstanding warrants caused by an increase in the company's share price.
Net losses for both the three and nine months ended September 30, 2023, were significantly higher compared to the same periods in 2022.